Scientific Researcher | The Second Hospital of Hebei Medical University | China
Dr. Arshad Mehmood is a dedicated neuroscientist whose research primarily focuses on neuroimmunology, neurodegenerative disorders, and molecular mechanisms underlying neurological diseases. His expertise encompasses investigating the role of MeCP2, CRISPR, mRNA, and targeted protein degradation technologies in diseases such as multiple sclerosis, neuromyelitis optica spectrum disorders, Alzheimer’s, Parkinson’s disease, ischemia-reperfusion injury, and stroke. He has contributed significantly to understanding inflammatory pathways, neuroimmune interactions, and molecular signaling mechanisms involved in central nervous system disorders. His research outputs are well recognized, with multiple publications in high-impact SCI-indexed journals, covering diverse topics such as retinal imaging in multiple sclerosis, the role of LINE-1 retrotransposons in neuroinflammation, and the potential of nanotechnology in overcoming blood-brain barrier challenges. Dr. Mehmood possesses extensive research skills including PCR, ELISA, Western blotting, RNA sequencing, flow cytometry, and advanced cell culture techniques. His professional experience also includes teaching physiology, cell biology, endocrinology, and genetics at university and college levels, reflecting his commitment to academic excellence and mentorship. He is proficient in various bioinformatics and statistical software tools such as SPSS, RaoSoft, and PrismPad, supporting his analytical and data interpretation abilities. His contributions to neurology and biotechnology have earned him professional recognition within the scientific community, where he continues to collaborate internationally on neuroinflammatory and translational research projects. Dr. Mehmood’s passion for advancing neuroscience through precision medicine and targeted molecular therapies underscores his vision to reduce the global burden of neurological diseases. He exemplifies scientific rigor, leadership, and innovation in clinical neuroscience, with a focus on developing future therapeutic strategies for complex brain disorders. He has acheived 239 Citations , 30 Documents , 8 h-index.
Profiles: Google Scholar | ORCID | Scopus | Research Gate
Featured Publications
1. Song, S., Guo, R., Mehmood, A., Zhang, L., Yin, B., Yuan, C., Zhang, H., Guo, L., et al. (2022). Liraglutide attenuates central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway. CNS Neuroscience & Therapeutics, 28(3), 422–434. Cited by 90.
2. Mehmood, A., Ali, W., Song, S., Din, Z. U., Guo, R. Y., Shah, W., Ilahi, I., Yin, B., Yan, H., et al. (2021). Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis. Brain and Behavior, 11(10), e2302. Cited by 40.
3. Khan, I., Khan, I., Jianye, Z., Xiaohua, Z., Khan, M., Hilal, M. G., Kakakhel, M. A., et al. (2022). Exploring blood microbial communities and their influence on human cardiovascular disease. Journal of Clinical Laboratory Analysis, 36(4), e24354. Cited by 38.
4. Haider, A., Wei, Z., Parveen, S., & Mehmood, A. (2023). The association between comorbid body dysmorphic disorder and depression: Moderation effect of age and mediation effect of body mass index and body image among Pakistani students. Middle East Current Psychiatry, 30(1), 11. Cited by 15.
5. Din, Z. U., Cui, B., Wang, C., Zhang, X., Mehmood, A., Peng, F., & Liu, Q. (2025). Crosstalk between lipid metabolism and EMT: Emerging mechanisms and cancer therapy. Molecular and Cellular Biochemistry, 480(1), 103–118. Cited by 14.